Information Processing: Rate-Based Investigation of Cell Physiological Changes along Design Space Development

References

1. 1.↵
   ICH. Pharmaceutical development. Q8(R2). Current Step 4′. Retrieved July 3, 2012 from http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q8_R1/Step4/Q8_R2_Guideline.pdf, 2009.
2. 2.↵
   U.S. Food and Drug Administration (FDA). Pharmaceutical cGMPs for the 21st Century—A Risk-Based Approach. Retrieved July 3, 2012 from http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/Manufacturing/QuestionsandAnswersonCurrentGoodManufacturingPracticescGMPforDrugs/UCM176374.pdf, 2004.
3. 3.↵
   ICH. Development and manufacture of drug substances (chemical entities and biotechnological/biological entities) Q11. Retrieved July 3, 2012 from http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q11/Q11_Step_4.pdf, 2012.
4. 4.↵
   EMA Guideline on Real Time Release Testing (formerly Guideline on Parametric Release). Retrieved July 3, 2012 from http://www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/03/WC500075028.pdf, 2010.
5. 5.↵
   1. Garcia T.,
   2. Cook G.,
   3. Nosal R

   . PQLI key topics—criticality, design space, and control strategy. J. Pharm. Innov. 2008, 3 (2), 60–68.

   OpenUrl
6. 6.↵
   1. Chirino A. J.,
   2. Mire-Sluis A

   . Characterizing biological products and assessing comparability following manufacturing changes. Nature Biotechnol. 2004, 22 (11), 1383–1391.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   1. Harms J.,
   2. Wang X.,
   3. Kim T.,
   4. Yang X.,
   5. Rathore A. S

   . Defining process design space for biotech products: case study of Pichia pastoris fermentation. Biotechnol. Prog. 2008, 24 (3), 655–662.

   OpenUrlPubMed
8. 8.↵
   1. Rathore A. S.,
   2. Yu M.,
   3. Yeboah S.,
   4. Sharma A

   . Case study and application of process analytical technology (PAT) towards bioprocessing: use of on-line high-performance liquid chromatography (HPLC) for making real-time pooling decisions for process chromatography. Biotechnol. Bioeng. 2008, 100 (2), 306–316.

   OpenUrlPubMed
9. 9.↵
   1. Woelbeling C

   . Creating quality by design/process analytical technology (PAT/QbD) management awareness. Pharm. Eng. 2008, 28, 1–9.

   OpenUrl
10. 10.↵
    1. Yu L

    . Pharmaceutical quality by design: product and process development, understanding, and control. Pharm. Res. 2008, 25 (4), 781–791.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Huang J.,
    2. Kaul G.,
    3. Cai C.,
    4. Chatlapalli R.,
    5. Hernandez-Abad P.,
    6. Ghosh K.,
    7. Nagi A

    . Quality by design case study: An integrated multivariate approach to drug product and process development. Int. J. Pharm. 2009, 382 (1–2), 23–32.

    OpenUrlPubMed
12. 12.↵
    1. Mandenius C.-F.,
    2. Graumann K.,
    3. Schultz T. W.,
    4. Premstaller A.,
    5. Olsson I. M.,
    6. Petiot E.,
    7. Clemens C.,
    8. Welin M

    . Quality-by-design for biotechnology-related pharmaceuticals. Biotechnology Journal 2009, 4 (5), 600–609.

    OpenUrlPubMed
13. 13.↵
    1. Rathore A. S

    . Roadmap for implementation of quality by design (QbD) for biotechnology products. Trends Biotechnol. 2009, 27 (9), 546–553.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Rathore A. S.,
    2. Mhatre R

    . Quality by Design for Biopharmaceuticals: Principles and Case Studies; John Wiley & Sons: Hoboken, NJ, 2009.
15. 15.↵
    1. Schmidt-Bader T

    . PAT und QbD im regulatorischen Umfeld der Pharmazeutischen Industrie. Chemie Ingenieur Technik 2010, 82, 415–428.

    OpenUrl
16. 16.↵
    1. Anurag P.,
    2. Rathore S.,
    3. Branning R.,
    4. Cecchini D

    . Quality: design space for biotech products. BioPharm Int. 2007, 20 (4).
17. 17.↵
    1. Winkle H

    . Implementing Quality by Design, PDA/FDA Joint Regulatory Conference, Washington, DC. Retrieved July 3, 2012 from http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/ucm103453.pdf, 2012.
18. 18.↵
    1. Ündey C.,
    2. Ertunç S.,
    3. Mistretta T.,
    4. Looze B

    . Applied advanced process analytics in biopharmaceutical manufacturing: Challenges and prospects in real-time monitoring and control. J. Process Control 2010, 20 (9), 1009–1018.

    OpenUrlCrossRefWeb of Science
19. 19.↵
    1. Kitano H

    . Systems biology: a brief overview. Science 2002, 295, 1662–1664.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Striedner G.,
    2. Cserjan-Puschmann M.,
    3. Potschacher F.,
    4. Bayer K

    . Tuning the transcription rate of recombinant protein in strong Escherichia coli expression systems through repressor titration. Biotechnol. Prog. 2003, 19 (5), 1427–1432.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Wechselberger P.,
    2. Herwig C

    . Model-based analysis on the relationship of signal quality to real-time extraction of information in bioprocesses. Biotechnol. Prog. 2012, 28 (1), 265–275.

    OpenUrlPubMed
22. 22.↵
    1. Herwig C.,
    2. Marison I.,
    3. von Stockar U

    . On-line stoichiometry and identification of metabolic state under dynamic process conditions. Biotechnol. Bioeng. 2001, 75 (3), 345–354.

    OpenUrlPubMed
23. 23.↵
    1. Jazini M.,
    2. Herwig C

    . Effect of post-induction substrate oscillation on recombinant alkaline phosphatase production expressed in Escherichia coli. J. Biosci. Bioeng. 2011, 112 (6), 606–610.

    OpenUrlPubMed
24. 24.↵
    1. Rozkov A.,
    2. Avignone-Rossa C. A.,
    3. Ertl P. F.,
    4. Jones P.,
    5. O'Kennedy R. D.,
    6. Smith J. J.,
    7. Dale J. W.,
    8. Bushell M. E

    . Characterization of the metabolic burden on Escherichia coli DH1 cells imposed by the presence of a plasmid containing a gene therapy sequence. Biotechnol. Bioeng. 2004, 88 (7), 909–915.

    OpenUrlPubMed
25. 25.↵
    1. Dietzsch C.,
    2. Spadiut O.,
    3. Herwig C

    . A dynamic method based on the specific substrate uptake rate to set up a feeding strategy for Pichia pastoris. Microb. Cell Fact. 2011, 10, 14.

    OpenUrlPubMed
26. 26.↵
    1. Dietzsch C.,
    2. Spadiut O.,
    3. Herwig C

    . A fast approach to determine a fed batch feeding profile for recombinant Pichia pastoris strains. Microb. Cell Fact. 2011, 10, 85.

    OpenUrlPubMed
27. 27.↵
    1. Wechselberger P.,
    2. Sagmeister P.,
    3. Engelking H.,
    4. Schmidt T.,
    5. Wenger J

    . Efficient feeding profile optimization using physiological information. Bioprocess Biosyst. Eng. 2012, in press.
28. 28.↵
    1. Jobé A. M.,
    2. Herwig C.,
    3. Surzyn M.,
    4. Walker B.,
    5. Marison I.,
    6. von Stockar U

    . Generally applicable fed-batch culture concept based on the detection of metabolic state by on-line balancing. Biotechnol. Bioeng. 2003, 82 (6), 627–639.

    OpenUrlPubMed
29. 29.↵
    1. Wilms B.,
    2. Hauck A.,
    3. Reuss M.,
    4. Syldatk C.,
    5. Mattes R.,
    6. Siemann M.,
    7. Altenbuchner J

    . High-cell-density fermentation for production of L-N-carbamoylase using an expression system based on the Escherichia coli rhaBAD promoter. Biotechnol. Bioeng. 2001, 73 (2), 95–103.

    OpenUrlCrossRefPubMed
30. 30.↵
    1. Baneyx F.,
    2. Mujacic M

    . Recombinant protein folding and misfolding in Escherichia coli. Nat. Biotechnol. 2004, 22 (11), 1399–1408.

    OpenUrlCrossRefPubMedWeb of Science
31. 31.↵
    1. Andersson L.,
    2. Yang S.,
    3. Neubauer P.,
    4. Enfors S. O

    . Impact of plasmid presence and induction on cellular responses in fed batch cultures of Escherichia coli. J. Biotechnol. 1996, 46 (3), 255–263.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Tong L

    . Extracellular expression, purification, and characterization of a winter flounder antifreeze polypeptide from Escherichia coli. Protein Expr. Purif. 2000, 18 (2), 175–181.

    OpenUrlPubMed
33. 33.↵
    1. Corchero J. L.,
    2. Cubarsí R.,
    3. Vila P.,
    4. Arís A.,
    5. Villaverde A

    . Cell lysis in Escherichia coli cultures stimulates growth and biosynthesis of recombinant proteins in surviving cells. Microbiol. Res. 2001, 156 (1), 13–18.

    OpenUrlPubMed
34. 34.↵
    1. Sommer B.,
    2. Friehs K.,
    3. Flaschel E

    . Efficient production of extracellular proteins with Escherichia coli by means of optimized coexpression of bacteriocin release proteins. J. Biotechnol. 2010, 145 (4), 350–358.

    OpenUrlPubMed
35. 35.↵
    1. Andersson L.,
    2. Strandberg L.,
    3. Enfors S.-O

    . Cell segregation and lysis have profound effects on the growth of Escherichia coli in high cell density fed batch cultures. Biotechnol. Prog. 1996, 12 (2), 190–195.

    OpenUrlPubMed
36. 36.↵
    1. Sandén A. M.,
    2. Prytz I.,
    3. Tubulekas I.,
    4. Förberg C.,
    5. Le H.,
    6. Hektor A.,
    7. Neubauer P.,
    8. Pragai Z.,
    9. Harwood C.,
    10. Ward A.,
    11. Picon A.,
    12. De Mattos J. T.,
    13. Postma P.,
    14. Farewell A.,
    15. Nyström T.,
    16. Reeh S.,
    17. Pedersen S.,
    18. Larsson G

    . Limiting factors in Escherichia coli fed-batch production of recombinant proteins. Biotechnol. Bioeng. 2003, 81 (2), 158–166.

    OpenUrlCrossRefPubMedWeb of Science
37. 37.↵
    1. Glick B. R

    . Metabolic load and heterologous gene expression. Biotechnol. Adv. 1995, 13 (2), 247–261.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Birnbaum S.,
    2. Bailey J. E

    . Plasmid presence changes the relative levels of many host cell proteins and ribosome components in recombinant Escherichia coli. Biotechnol. Bioeng. 1991, 37 (8), 736–745.

    OpenUrlCrossRefPubMed
39. 39.↵
    1. Voellmy R.,
    2. Goldberg A. L

    . Guanosine-5′-diphosphate-3′-diphosphate (ppGpp) and the regulation of protein breakdown in Escherichia coli. J. Biol. Chem. 1980, 255 (3), 1008–1014.

    OpenUrlFREE Full Text
40. 40.↵
    1. Farewell A.,
    2. Neidhardt F. C

    . Effect of temperature on in vivo protein synthetic capacity in Escherichia coli. J. Bacteriol. 1998, 180 (17), 4704–4710.

    OpenUrlAbstract/FREE Full Text
41. 41.↵
    1. Landgrebe D.,
    2. Haake C.,
    3. Höpfner T.,
    4. Beutel S.,
    5. Hitzmann B.,
    6. Scheper T.,
    7. Rhiel M.,
    8. Reardon K. F

    . On-line infrared spectroscopy for bioprocess monitoring. Appl. Microbiol. Biotechnol. 2010, 88 (1), 11–22.

    OpenUrlPubMed
42. 42.↵
    1. Dietzsch C.,
    2. Spadiut O.,
    3. Herwig C

    . On-line multiple component analysis for efficient quantitative bioprocess development. J. Biotechnol. 2012, in press.